Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Downstream Processing Market Revenue Estimated to Grow at a CAGR of 16.4%

Downstream Processing Market Revenue Estimated To Grow At A CAGR Of 16.4%

North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. North America (comprising the U.S. and Canada) accounted for the largest share of the global market in 2016. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region.

Downstream Processing Market, by Product:

1. Chromatography Columns and Resins
2. Filters
3. Membrane Adsorbers
4. Single-use Products
5. Other Products (Consumables and Accessories)

On the basis of product, the market is classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products. In 2016, the chromatography columns and resins segment accounted for the largest share of the market. The constant need for newer and different types of columns and resins is likely to fuel market growth.

Get Crucial Industry Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930

Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment.

Key Players in Downstream Processing Market:

The Downstream Processing Market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).

Downstream Processing Market, by End User:

1. Biopharmaceutical Manufacturers
2. Contract Manufacturing Organizations (CMOs)

Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical manufacturers segment accounted for the largest share of the market. The increasing demand for biopharmaceuticals among the aging population is expected to accelerate the growth of the biopharmaceutical manufacturers’ end-user segment.

Know more Insights:
https://www.marketsandmarkets.com/Market-Reports/downstream-processing-market-73180930.html



This post first appeared on Personal, please read the originial post: here

Share the post

Downstream Processing Market Revenue Estimated to Grow at a CAGR of 16.4%

×

Subscribe to Personal

Get updates delivered right to your inbox!

Thank you for your subscription

×